Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Societe Generale Downgrades Alcon to Sell

Societe Generale Downgrades Alcon to Sell

Societe Generale analyst Delphine Le Louet downgrades Alcon (NYSE:ALC) from Hold to Sell.

byBenzinga Newsdesk

November 17, 2022

1 minute read

Societe Generale analyst Delphine Le Louet downgrades Alcon (NYSE:ALC) from Hold to Sell.

Tenable Gets Price Target Cuts By Analysts Following Weak Revenue Forecast, Shares Plunge

By Lisa Levin

April 25, 8:09 AM

Tenable Holdings Inc (NASDAQ: TENB) reported better-than-expected first-quarter results but issued revenue guidance below analyst estimates.

TENB

News

What’s Going On With Rivian Stock?

By Henry Khederian

January 3, 3:47 PM

Rivian Automotive Inc (NASDAQ: RIVN) shares are trading lower by 2.7% to $20.54 during Wednesday's session.

RIVN

GM Bolsters Finances with $6B Credit – Is It For Bracing Extended UAW Strikes?

By Nabaparna Bhattacharya

October 4, 10:40 AM

General Motors Company (NYSE: GM) established a $6 billion credit line with a 364-day revolving credit agreement with JP Morgan Chase & Co. (NYSE: JPM).

Biora Therapeutics To Present Clinical Data On Device Function Of The NaviCap Oral Delivery Platform At Digestive Disease Week 2024

By Benzinga Newsdesk

May 6, 8:18 AM

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present clinical data on device function of the NaviCap™ Targeted Oral Delivery

BIOR

Societe Generale Downgrades Alcon to Sell

Related Posts

Tenable Gets Price Target Cuts By Analysts Following Weak Revenue Forecast, Shares Plunge

What’s Going On With Rivian Stock?

GM Bolsters Finances with $6B Credit – Is It For Bracing Extended UAW Strikes?

Biora Therapeutics To Present Clinical Data On Device Function Of The NaviCap Oral Delivery Platform At Digestive Disease Week 2024